DPP4 and type 2 diabetes mellitus: This is particularly important as DPP-4 inhibitor in combination with metformin is currently the most widely prescribed combination for type 2 diabetes, owing to additional benefits such as increased efficacy, tolerability, and lowered risk of hypoglycemia (63).